Masanin kimiyya wanda ya taimaka wajan yaƙin SARS maganin COVID-19

s

Cheng Jing

Cheng Jing, masanin kimiyyar ne wanda kungiyarsa ta kirkiro DNA ta farko ta "guntu" ta China don gano SARS shekaru 17 da suka gabata, tana ba da gudummawa sosai a yakin da ake yi da cutar ta COVID-19.

A kasa da mako guda, ya jagoranci wata ƙungiyar don ƙirƙirar kit wanda zai iya gano guda ƙwayoyin cuta guda shida, ciki har da COVID-19, kuma biyan bukatun gaggawa don ganewar asibiti.

An haife shi a shekara ta 1963, Cheng, shugaban kamfanin mallakar dabbobi na jihar CapitalBio Corp, ya kasance mataimakin shugaban majalisar wakilan jama'ar kasar kuma masanin ilmin injiniya na kasar Sin.

A ranar 31 ga watan Janairu, Cheng ya samu kira daga Zhong Nanshan, mashahurin masanin cututtukan numfashi, game da cututtukan cututtukan coronavirus, kamar yadda rahoto da Kimiyya da Fasaha Daily.

Zhong ya fada masa matsalolin da ke faruwa a asibitoci dangane da gwajin kwayoyin nucleic acid.

Cutar cututtukan COVID-19 da mura sunyi kama, wanda ya sanya ingantaccen gwaji har ma da mahimmanci.

Bayyana ƙwayar cutar da sauri don ware marasa lafiya don ƙarin magani da rage kamuwa da cuta yana da mahimmanci don magance fashewar.

A zahiri, Cheng ya riga ya kafa ƙungiyar don yin gwaji a kan littafin coronavirus na labari kafin ya sami kira daga Zhong.

A farkon farawa, Cheng ya jagoranci tawagar daga Jami'ar Tsinghua da kamfanin don tsayawa kan lab da rana dare da rana, suna amfani da kowane minti don bunkasa sabon guntu da na'urar gwaji.

Cheng yakan kasance da noodles na lokaci-lokaci don abincin dare a lokacin. Ya kawo masa kaya tare da shi kowace rana don su kasance cikin shirin zuwa yaƙin.

Cheng ya ce "Ya dauki makwanni biyu don samar da kwakwalwar kwayoyin halittar kwayar halitta ta SARS a 2003. A wannan karon, ba mu kashe mako guda ba," in ji Cheng.

"Idan ba da dimbin kwarewar da muka tara a shekarun baya da kuma ci gaba da tallafawa kasar nan ga wannan bangare ba, da ba za mu iya kammala aikin cikin sauri ba."

Guntun da aka yi amfani da shi don gwada kwayar cutar SARS ya bukaci awanni shida don samun sakamako. Yanzu, sabon guntu na kamfanin na iya gwada ƙwayoyin cuta na numfashi 19 a lokaci ɗaya a cikin sa'o'i ɗaya da rabi.

Kodayake ƙungiyar ta rage lokacin bincike da haɓaka na'urar guntu da na'urar gwaji, ba a sauƙaƙe tsarin amincewa kuma ba a rage daidaito ba kwata-kwata.

Cheng ya tuntubi asibitoci hudu don gwaje-gwaje na asibiti, yayin da ma'aunin masana'antu ke da uku.

Cheng ya ce, "mun fi kwanciyar hankali fiye da na karshe, muna fuskantar annobar," in ji Cheng. "Idan aka kwatanta da 2003, iyawarmu na bincike, ingancin samarwa da karfin masana'antu duk sun inganta sosai."

A ranar 22 ga Fabrairu, Hukumar Kula da Kayayyakin Kiwon Lafiyar ta Kasa ta amince da kitse da aka kirkiro kuma an yi amfani da shi cikin hanzari kan layin gaba.

A ranar 2 ga Maris, Shugaba Xi Jinping ya duba birnin Beijing domin kula da shawo kan cutar da kuma rigakafin kimiyya. Cheng ya ba da rahoto na mintina 20 game da amfani da sabuwar fasahar a rigakafin cutar annoba da nasarorin binciken da aka samu na abubuwan gano ƙwayoyin cuta.

An kafa shi ne a cikin 2000, babban kamfanin ba da fasaha na Babban Bankin CapitalBio yana cikin yankin Development na Fasaha-Fasaha na Beijing, ko kuma Beijing E-Town.

Kusan kamfanoni 30 a yankin sun halarci kai tsaye a yaƙi da cutar ta hanyar haɓakawa da kuma kera wurare kamar injinan numfashi, robotsar jini, injunan tsarkake jini, wuraren aikin CT scan da magunguna.

A yayin zaman biyu na wannan shekara, Cheng ya ba da shawarar cewa kasar ta hanzarta kafa cibiyar sadarwa mai hankali kan manyan cututtukan da ke kamuwa da cuta, wadanda za su iya tura bayanai da sauri game da cutar da marasa lafiya ga hukumomi.


Lokacin aikawa: Jun-12-2020